相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Genetic and epigenetic insights into cutaneous T-cell lymphoma
Cornelis P. Tensen et al.
BLOOD (2022)
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Amy C. M. Musiek et al.
DERMATOLOGY AND THERAPY (2022)
Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab
Yuhei Kamada et al.
LEUKEMIA & LYMPHOMA (2022)
Impact of Mogamulizumab in Real-Life Advanced Cutaneous T-Cell Lymphomas: A Multicentric Retrospective Cohort Study
Marie Jouandet et al.
CANCERS (2022)
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Pierluigi Porcu et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Mycosis Fungoides and Sezary Syndrome: Updates and Review of Current Therapy
Hiroaki Kamijo et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
Amy C.M. Musiek et al.
EUROPEAN JOURNAL OF CANCER (2021)
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sezary Syndrome
Kelsey E. Hirotsu et al.
JAMA DERMATOLOGY (2021)
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity
Joonhee Park et al.
BLOOD (2021)
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial
R. A. Cowan et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Mogamulizumab-induced vitiligo in patients with Sezary syndrome: three cases
Abdullah S. Algarni et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2021)
Histopathologic Characterization of Mogamulizumab-associated Rash
Jennifer Y. Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients
Gabor Dobos et al.
CANCERS (2020)
Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sezary syndrome (SS)
Doaa Shalabi et al.
CHINESE CLINICAL ONCOLOGY (2019)
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Willemze et al.
ANNALS OF ONCOLOGY (2018)
Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment
Lorenzo Cerroni
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2018)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim et al.
LANCET ONCOLOGY (2018)
Dermatological Complications After Solid Organ Transplantation
Luigi Naldi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
H. Miles Prince et al.
LANCET (2017)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Julia J. Scarisbrick et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
Xiao Ni et al.
CLINICAL CANCER RESEARCH (2015)
Multicenter Phase II Study of Mogamulizumab ( KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Michinori Ogura et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Skin toxicities associated with epidermal growth factor receptor inhibitors
Tianhong Li et al.
TARGETED ONCOLOGY (2009)
Mycosis fungoides and Sezary syndrome
Sam T. Hwang et al.
LANCET (2008)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Significant impact of cutaneous T-cell lymphoma on patients' quality of life - Results of a 2005 National Cutaneous Lymphoma Foundation Survey
Marie-France Demierre et al.
CANCER (2006)